Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Molinaro

Showing results (141-150 of 208) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|October 15, 2021
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imagingJulia Cluceru, Yannet Interian, Joanna J Phillips, et al.
Journal of Neuro-Oncology|September 15, 2016
Expression and prognostic impact of immune modulatory molecule PD-L1 in meningiomaSeunggu J Han, Gerald Reis, Gary Kohanbash, et al.
Cancer|August 1, 2017
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomasMichael Wahl, Susan M Chang, Joanna J Phillips, et al.
Neuro-Oncology|August 20, 2016
Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivorsErika Roddy, Katherine Sear, Erin Felton, et al.
NPJ Precision Oncology|November 18, 2024
Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapyZe Zhang, Kartik Sehgal, Keisuke Shirai, et al.
Neuro-Oncology Practice|September 27, 2019
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survivalChristopher H Chapman, Jared H Hara, Annette M Molinaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in GliomaAnupam Kumar, Esraa Mohamed, Schuyler Tong, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2017
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomaJennifer L Clarke, Annette M Molinaro, Juan R Cabrera, et al.
Cancer Discovery|February 1, 2015
The genetics of splicing in neuroblastomaJustin Chen, Christopher S Hackett, Shile Zhang, et al.
Journal of Neuro-Oncology|October 2, 2017
Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patientsDaniel I Jacobs, Yanhong Liu, Konrad Gabrusiewicz, et al.
Pageof 21

Showing results (141-150 of 208) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|October 15, 2021
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imagingJulia Cluceru, Yannet Interian, Joanna J Phillips, et al.
Journal of Neuro-Oncology|September 15, 2016
Expression and prognostic impact of immune modulatory molecule PD-L1 in meningiomaSeunggu J Han, Gerald Reis, Gary Kohanbash, et al.
Cancer|August 1, 2017
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomasMichael Wahl, Susan M Chang, Joanna J Phillips, et al.
Neuro-Oncology|August 20, 2016
Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivorsErika Roddy, Katherine Sear, Erin Felton, et al.
NPJ Precision Oncology|November 18, 2024
Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapyZe Zhang, Kartik Sehgal, Keisuke Shirai, et al.
Neuro-Oncology Practice|September 27, 2019
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survivalChristopher H Chapman, Jared H Hara, Annette M Molinaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in GliomaAnupam Kumar, Esraa Mohamed, Schuyler Tong, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2017
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomaJennifer L Clarke, Annette M Molinaro, Juan R Cabrera, et al.
Cancer Discovery|February 1, 2015
The genetics of splicing in neuroblastomaJustin Chen, Christopher S Hackett, Shile Zhang, et al.
Journal of Neuro-Oncology|October 2, 2017
Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patientsDaniel I Jacobs, Yanhong Liu, Konrad Gabrusiewicz, et al.
Pageof 21